A PHASE 3, DOUBLE-BLIND, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH
A PHASE 3, DOUBLE-BLIND, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH
批准号:
7606043
负责人:
Carlos Milla
金额:
$3.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30
关键词:
AztreonamBreathingClinicalComputer Retrieval of Information on Scientific Projects DatabaseDouble-Blind MethodEnd PointFundingGrantInstitutionLungPhasePseudomonas aeruginosaResearchResearch PersonnelResourcesSafetySolutionsSourceTimeTobramycinUnited States National Institutes of Healthcystic fibrosis patientsdaydesignimprovedrandomized placebo controlled trialtreatment duration
中文摘要
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
This study is designed to assess the safety and efficacy of a 28-day treatment with Aztreonam Lysinate for Inhalation (AI, Cayston) and the ability of AI to maintain or improve clinical status following a 28-day course of Tobramycin Solution for Inhalation (TSI, TOBI) therapy in cystic fibrosis (CF) patients with pulmonary Pseudomonas aeruginosa (PA). The primary endpoint of this study is to evaluate the time to need for inhaled or IV antibotics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis of Pf Bacteriophages in Pseudomonas Cystic Fibrosis lung Infections
-
批准号:10463594
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2019
-
负责人:Carlos Milla
-
依托单位:
Pathogenesis of Pf Bacteriophages in Pseudomonas Cystic Fibrosis lung Infections
-
批准号:9803696
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2019
-
负责人:Carlos Milla
-
依托单位:
INHALED SODIUM PYRUVATE FOR THE TREATMENT OF CYSTIC FIBROSIS A PHASE I, DOUBLE
-
批准号:7606079
-
项目类别:
-
资助金额:$0.94万
-
财政年份:2006
-
负责人:Carlos Milla
-
依托单位:
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 28-DAY STUDY OF DENUFOSOL TETRAS
-
批准号:7606078
-
项目类别:
-
资助金额:$0.94万
-
财政年份:2006
-
负责人:Carlos Milla
-
依托单位:
ASSESSMENT OF INDUCED SPUTUM AS A TOOL TO EVALUATE ANTI-INFLAMMATORY AGENTS IN C
-
批准号:7375926
-
项目类别:
-
资助金额:$0.86万
-
财政年份:2005
-
负责人:Carlos Milla
-
依托单位:
MULTI-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II STUDY OF AEROSOLIZED TG
-
批准号:7206506
-
项目类别:
-
资助金额:$4.26万
-
财政年份:2005
-
负责人:Carlos Milla
-
依托单位:
A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 28-DAY STUDY OF D
-
批准号:7375973
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2005
-
负责人:Carlos Milla
-
依托单位:
A PHASE 3, DOUBLE-BLIND, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH
-
批准号:7375983
-
项目类别:
-
资助金额:$2.47万
-
财政年份:2005
-
负责人:Carlos Milla
-
依托单位:
MULTI-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II STUDY OF AEROSOLIZED TG
-
批准号:7375916
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2005
-
负责人:Carlos Milla
-
依托单位:
A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 28-DAY STUDY OF IN
-
批准号:7206486
-
项目类别:
-
资助金额:$0.76万
-
财政年份:2005
-
负责人:Carlos Milla
-
依托单位:
Biomarker Core
-
批准号:8225674
-
项目类别:
-
资助金额:$60.93万
-
财政年份:--
-
负责人:Carlos Milla
-
依托单位:
Biomarker Core
-
批准号:8484437
-
项目类别:
-
资助金额:$58.0万
-
财政年份:--
-
负责人:Carlos Milla
-
依托单位:
Biomarker Core
-
批准号:8381254
-
项目类别:
-
资助金额:$60.93万
-
财政年份:--
-
负责人:Carlos Milla
-
依托单位:
Biomarker Core
-
批准号:8857549
-
项目类别:
-
资助金额:$52.79万
-
财政年份:--
-
负责人:Carlos Milla
-
依托单位:
Biomarker Core
-
批准号:8676925
-
项目类别:
-
资助金额:$58.78万
-
财政年份:--
-
负责人:Carlos Milla
-
依托单位:
海外基金